Print-friendly View
Resources for Health Professionals and Patients
| Review: Phase 2 Study of the Safety and Efficacy of Vicriviroc, a CCR5 Inhibitor, in HIV-1 Infected, Treatment-Experienced Patients: AIDS Clinical Trials Group 5211 | |
Attached file: |
(Russian, 233 kb)
Review in Russian
|
Link to document(s) | http://www.ncbi.nlm.nih.gov... |
Author(s): | Gulick R., et al. |
Document type: | Literature Reviews |
Language: | English, Russian |
Original language of document: | Russian |
Publication date: | July 15, 2007 |
Primary area(s) of focus: | HIV/AIDS |
Secondary areas of focus: | Adherence to treatment regimens, Clinical trials |
Submited by: | Victor Stanilevskiy |
Material written specifically for patients: | No |
Date of entry: | August 1, 2007 |
Pages: | 3 |
| This article review was prepared by the Internet project MedMir.com, which is aimed to provide Russian speaking medical professionals with timely, comprehensive and relevant clinical information in the form of the Russian language summaries of clinical study reports published in the top world medical journals. | |
Overall user rating: | Not yet reviewed |
